Could a simple scan replace kidney biopsies? new study tests a tracer that sees scarring
NCT ID NCT07712679
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study explores whether a special PET/CT scan using a tracer called 68Ga-FAPI can detect fibrosis (scarring) in the kidneys of people with chronic kidney disease. Currently, scarring can only be confirmed through a kidney biopsy, which is invasive and can miss areas of damage. The researchers will compare the scan results with biopsy findings to see if the imaging method accurately reflects the amount of fibrosis. If it works, this could lead to a safer, more complete way to monitor kidney disease progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 68Ga-FAPI tracer for PET/CT imaging
- What this could lead to
- If successful, this imaging method could allow doctors to assess kidney scarring without an invasive biopsy, improving monitoring of chronic kidney disease.
- What could go wrong
- This is a small pilot study with only 30 participants, so results may not apply broadly. The tracer's accuracy in detecting fibrosis is still unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
General hospital Vienna
RECRUITINGVienna, State of Vienna, 1090, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drug that boosts red blood cells help anemia in kidney disease?
- Predicting kidney trouble in older adults: a data-driven approach to clearer lab results
- Could delaying kidney implant during heart transplant reduce complications?
- Can a new tablet formulation improve how a kidney disease drug is absorbed?
- New drug aims to reduce kidney damage in chronic disease
- Contrast dye Double-Dose: new study tracks kidney fallout in ICU patients